Literature DB >> 29900993

Neutrophilic Alveolitis and High Serum Pro-Brain Natriuretic Peptide Level may be Indicators of Pulmonary Functional Impairment in Connective Tissue Disorders.

Serap Unculu1, Özlem Erçen Diken1, Aydın Çiledağ1, Aydan Ikincioğullari2, Demet Karnak1, Oya Kayacan1, Murat Turgay3.   

Abstract

OBJECTIVES: This study aims to assess the role of several diagnostic tests and tools, immune markers, and the association between serum pro-brain natriuretic peptide levels and other parameters in patients with collagen tissue disorders with pulmonary involvement. PATIENTS AND METHODS: In this prospective study, 62 patients (17 males, 45 females; mean age 58.1±13.6 years; range 24 to 87 years) with pulmonary involvement of connective tissue disorders were evaluated using several functional parameters (six-minute walking test, serum pro-brain natriuretic peptide, echocardiographic measurement of the pulmonary pressure, respiratory functional parameters, and blood pressure measurement), bronchoalveolar lavage differential cytology and/or flow cytometric analysis.
RESULTS: Duration of disease was 7.6 years. Diagnoses included rheumatoid arthritis (38.7%), scleroderma (38.7%), primary Sjögren's syndrome (16.1%), mixed collagen tissue disorder (4.8%), and systemic lupus erythematosus (1.6%). Pulmonary hypertension was present in 38.7% of the patients with the highest incidence of rheumatoid arthritis showing reduced respiratory functions, partial oxygen pressure, and six-minute walk distance, as well as increased serum pro-brain natriuretic peptide and neutrophilic alveolitis.
CONCLUSION: High serum pro-brain natriuretic peptide levels and neutrophilic alveolitis may provide diagnostic clues for a possible diagnosis of pulmonary hypertension and impaired respiratory functions.

Entities:  

Year:  2015        PMID: 29900993      PMCID: PMC5827862          DOI: 10.5606/ArchRheumatol.2016.5720

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  30 in total

1.  Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management.

Authors:  Heather Racz; Sanjay Mehta
Journal:  J Rheumatol       Date:  2006-09       Impact factor: 4.666

2.  The clinical significance of serum N-terminal pro-brain natriuretic peptide in systemic sclerosis patients.

Authors:  Hyo Jin Choi; Young Kee Shin; Hyun Joo Lee; Joo Young Kee; Dong Woo Shin; Eun Young Lee; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song
Journal:  Clin Rheumatol       Date:  2007-09-25       Impact factor: 2.980

Review 3.  The role of small airways in obstructive airway diseases.

Authors:  P-R Burgel
Journal:  Eur Respir Rev       Date:  2011-03

4.  A longitudinal study of pulmonary involvement in primary Sjögren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography.

Authors:  F Salaffi; P Manganelli; M Carotti; S Baldelli; P Blasetti; S Subiaco; M C Binci; E Bichi Secchi; F Amici; C Cervini
Journal:  Br J Rheumatol       Date:  1998-03

5.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

6.  Raised pulmonary artery pressures measured with Doppler echocardiography in rheumatoid arthritis patients.

Authors:  J K Dawson; N G Goodson; D R Graham; M P Lynch
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

Review 7.  Interstitial lung diseases in collagen vascular diseases.

Authors:  C Lamblin; C Bergoin; T Saelens; B Wallaert
Journal:  Eur Respir J Suppl       Date:  2001-09

Review 8.  Lower limit of normal or FEV1/FVC < 0.70 in diagnosing COPD: an evidence-based review.

Authors:  Firdaus A A Mohamed Hoesein; Pieter Zanen; Jan-Willem J Lammers
Journal:  Respir Med       Date:  2011-02-05       Impact factor: 3.415

9.  Benefits of oxygen on exercise performance and pulmonary hemodynamics in patients with COPD with mild hypoxemia.

Authors:  Keisaku Fujimoto; Yukinori Matsuzawa; Shinji Yamaguchi; Tomonobu Koizumi; Keishi Kubo
Journal:  Chest       Date:  2002-08       Impact factor: 9.410

10.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.